A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

This study has been terminated.
(Due to non-recruitment, the study is being halted. There are no major safety or tolerability concerns in the study conducted so far.)
Sponsor:
Information provided by (Responsible Party):
Piramal Enterprises Limited
ClinicalTrials.gov Identifier:
NCT01674348
First received: August 21, 2012
Last updated: August 2, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)